Group 1: Financial Performance - The company achieved steady revenue growth and rapid profit increase in 2024, driven by government policies and expansion in various business sectors, including consumer electronics and drones [2][3] - The projected total cash dividend for 2024 is approximately ¥21,281,632.19, with a distribution of ¥1.30 per 10 shares based on a total share capital of 163,704,863 shares [7] Group 2: Cost Control Measures - The company has implemented cost control measures through increased automation and comprehensive budget management, leading to improved economic operation quality [4] Group 3: Financing Plans - The company initiated a refinancing plan in 2024, aiming to raise up to ¥450 million through the issuance of convertible bonds, focusing on R&D and production of automotive and industrial connectors [5] Group 4: Overseas Operations - A production base has been established in Thailand to enhance support for overseas customers, with the first factory completed in January 2025 and the second factory expected to be operational soon [6]

Company Activities - No companies submitted IPO applications to the review committee last week, and no companies from Zhejiang passed the review [3] - Three Zhejiang companies announced merger and acquisition activities, and one company announced refinancing [3] - Yongli Co. plans to acquire 50% equity of Ketaike for 0.09 million yuan to strengthen its control over the subsidiary [6] - Haixing Holdings intends to sell 5% equity of Haixing Electric for 5.9 billion yuan, with the buyer becoming a significant shareholder [7] - Aidi Kang Holdings and Hangzhou Aidi Kang plan to acquire 100% equity of Yuande Weikang and Yuande Youqin for 2.28 billion yuan [8][9] - Gujia Home intends to raise 19.97 billion yuan through a private placement to finance projects, with a share price set at 19.15 yuan [10] Financial Policies - The central bank announced ten policy measures to stabilize the market, including a 0.5% reduction in the reserve requirement ratio and a 0.1% decrease in policy interest rates [5] - Financial regulatory authorities will introduce eight incremental policies to support the real estate sector and long-term investments [5]

Group 1: Financial Performance - In 2024, the company achieved a revenue of 418.96 million CNY, representing a year-on-year growth of 9.98% [3] - The net profit for 2024 was -0.744 million CNY, indicating a loss compared to the previous year [3] - The company plans to distribute cash dividends of 5.00 CNY per 10 shares, totaling approximately 28.76 million CNY, despite the negative net profit [8] Group 2: Cost and Expense Management - Management expenses increased by 45.39% and sales expenses rose by 31.25% in 2024 due to rapid growth in personnel [3] - R&D expenses surged by 94.47%, reflecting the company's commitment to innovation and development [6] Group 3: Market and Business Strategy - The company has a foreign sales ratio of approximately 38%, with no significant impact from current tariff policies on completed orders [2] - The construction of the Thailand factory is progressing as planned, with an expected operational start in 2026 [3] - The company is focusing on expanding its market presence both domestically and internationally, particularly in South America [5] Group 4: Product Development and Innovation - The company is actively developing new products, including dialysis solutions and CRRT products, to enhance its product portfolio [4] - The company has acquired CRRT business assets and plans to complete a comprehensive business ecosystem within three years [4] Group 5: Industry Outlook - The medical device industry, particularly in blood purification, is expected to grow due to increasing global end-stage renal disease patients and supportive national policies [6] - The company remains optimistic about the future of the industry, citing the essential nature of its products and the relatively low impact of market fluctuations [6]

近日，云南建投集团所属基投公司已运营高速——呈澄高速项目获得再融资18亿元，实现了降低贷款利率、延长贷款期限、盘活沉淀资产的"一箭三雕"成 效。这是集团首笔通过再融资创新模式盘活高速公路资产的业务，为集团资产盘活工作开辟了新路径。 呈澄高速是建投集团自主投资、建设和运营的首条高速公路，起点位于昆明市呈贡马金铺乡小营村，终点与龙街互通连接，全长15.316公里，采用双向六 车道高速公路标准建设，于2016年6月全线通车运营。自通车以来，凭借卓越服务质量，呈澄高速荣获全国青年文明号、全国高速公路优质服务项目和昆 明市优质工程"春城杯"特等奖，路况服务质量考核成绩多次领跑全省。其建成通车，为澄江市融入滇中城市群"1小时经济圈"提供了强大助力，极大地优 化了区域交通格局，成功带动沿线城镇的经济发展，有效促进文旅产业和乡村振兴，成为连通昆明与澄江两地的幸福路、致富路。 基投公司精心制定方案，积极主动向银行推介，争取邮储银行18亿元再融资，成功置换了项目存量高息债务，将贷款期限延长7年，利率大幅下降60个基 点，有效优化了项目债务结构，为公司节省利息约6000万元。同时，还为公司融入增量资金，实现沉淀资产激活转化，改善集 ...

Core Viewpoint - Windshun Tire Co., Ltd. has withdrawn its application for a simplified procedure to issue shares to specific targets, leading to the termination of the review by the Shanghai Stock Exchange [1] Group 1: Financing and Share Issuance - The company planned to issue 53,003,533 shares, aiming to raise a total of 30 million yuan, not exceeding 300 million yuan and 20% of the company's net assets as of the end of the last fiscal year [2] - The net proceeds from the fundraising would be fully allocated to the "High-Performance Giant Engineering Radial Tire Expansion and Efficiency Improvement Project" [2][3] Group 2: Financial Performance - The company's projected revenues for 2022, 2023, and 2024 are 498.79 million yuan, 573.88 million yuan, and 670.81 million yuan, respectively [3] - The net profit attributable to shareholders for the same years is expected to be 84.52 million yuan, 348.86 million yuan, and 280.94 million yuan, showing a decline in 2024 [3][4] - The company's operating revenue in 2024 is projected to increase by 16.89% year-on-year, while the net profit attributable to shareholders is expected to decrease by 19.47% [4] Group 3: Shareholding Structure - China National Chemical Corporation directly holds 41.94 million shares, accounting for 57.50% of the total share capital, making it the controlling shareholder [5] - China National Chemical Asset Management Co., Ltd. holds an additional 1.51% of shares and is considered to have a concerted action relationship with the rubber company [5]

答：《监管规则适用指引——发行类第9号：研发人员及研发投入》明确，对于既从事研发活动又从事非研发活动的非全时研发人员，当期研发工时占比低 于50%的，原则上不应认定为研发人员。审核实践发现，部分发行人存在人员内部调岗、员工实际从事活动与工作关系所属部门不一致、将实习期等纳入 工时统计等情形。对于上述情形，在进行研发人员认定时应重点把握以下方面： 文/梧桐小新 2023年2月上交所实施全面注册制后，将原分期发布的《科创板发行上市审核动态》变更为《上交所发行上市审核动态》。2023年至今，《上交所发行上市审核 动态》已发布13期，本文将这13期中42个"问题解答"汇总，供读者们分享、收藏。 | 期数 | 间题解答 | | --- | --- | | 2025年第1期 | 1、 研发人员认定注意事项 | | | 涉产学研合作技术成果的核查要求 2、 | | | 3、再融资项目中介机构违法违规的核查要求 | | | 4、股份支付授予日的认定 | | 2024年第6期 | 1、并购重组项目预沟通的注意事项 | | | 2、再融资募集资金投向的披露和说明注意事项 | | | 3、主板板块定位条件中行业代表性的关注要点 | ...